Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PP-HEP: Postpartum Heparin Pilot
NCT05878899Phase 3Completed
- Start
- May 2022
- Primary completion
- Mar 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in venous thromboembolism (VTE). Started May 2022; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT05878899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05878899.